- BABA Dashboard
-
Financials
- Filings
- Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Alibaba Group Holding Limited (BABA) Financial statements
Company Profile
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||
Cost of Revenue | |||||||||||
Gross Profit | |||||||||||
Gross Profit Margin (%) | |||||||||||
R&D Expense | |||||||||||
SG&A Expense | |||||||||||
Total Operating Expenses | |||||||||||
Operating Income or Loss | |||||||||||
Operating Margin (%) | |||||||||||
Interest Expense | |||||||||||
Total Other Income/Expenses | |||||||||||
Income Before Tax | |||||||||||
Income Tax Expense | |||||||||||
Income from Continuing Ops. | |||||||||||
Net Income | |||||||||||
Net Profit Margin (%) | |||||||||||
Net Income Available to Common Shareholders | |||||||||||
Basic EPS | |||||||||||
Diluted EPS | |||||||||||
Basic Average Shares | |||||||||||
Diluted Average Shares |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||
Cost of Revenue | |||||||||||
Gross Profit | |||||||||||
Gross Profit Margin (%) | |||||||||||
R&D Expense | |||||||||||
SG&A Expense | |||||||||||
Total Operating Expenses | |||||||||||
Operating Income or Loss | |||||||||||
Operating Margin (%) | |||||||||||
Interest Expense | |||||||||||
Total Other Income/Expenses | |||||||||||
Income Before Tax | |||||||||||
Income Tax Expense | |||||||||||
Income from Continuing Ops. | |||||||||||
Net Income | |||||||||||
Net Profit Margin (%) | |||||||||||
Net Income Available to Common Shareholders | |||||||||||
Basic EPS | |||||||||||
Diluted EPS | |||||||||||
Basic Average Shares | |||||||||||
Diluted Average Shares |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||
Cash & Cash Equivalents | |||||||||||
Marketable Securities | |||||||||||
Receivables | |||||||||||
Inventories | |||||||||||
Other Current Assets | |||||||||||
Total Current Assets | |||||||||||
Non-Current Assets | |||||||||||
Marketable Securities | |||||||||||
PPE Net | |||||||||||
Intangibles inc. Goodwill | |||||||||||
Other Non-Current Assets | |||||||||||
Total Non-Current Assets | |||||||||||
Total Assets | |||||||||||
Current Liabilities | |||||||||||
Accounts Payable | |||||||||||
Deferred Revenues | |||||||||||
Debt, Current | |||||||||||
Accrued Liabilities | |||||||||||
Other Current Liabilities | |||||||||||
Total Current Liabilities | |||||||||||
Non-Current Liabilities | |||||||||||
Deferred Revenues | |||||||||||
Debt, Non-Current | |||||||||||
Other Non-Current Liabilities | |||||||||||
Total Non-Current Liabilities | |||||||||||
Total Liabilities | |||||||||||
Shareholders' Equity | |||||||||||
Common Stock | |||||||||||
Additional Paid-In Capital | |||||||||||
Retained Earnings | |||||||||||
Other Shareholders' Equity | |||||||||||
Total Shareholders' Equity | |||||||||||
Total Liabilities & Shareholders' Equity |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||
Cash & Cash Equivalents | |||||||||||
Marketable Securities | |||||||||||
Receivables | |||||||||||
Inventories | |||||||||||
Other Current Assets | |||||||||||
Total Current Assets | |||||||||||
Non-Current Assets | |||||||||||
Marketable Securities | |||||||||||
PPE Net | |||||||||||
Intangibles inc. Goodwill | |||||||||||
Other Non-Current Assets | |||||||||||
Total Non-Current Assets | |||||||||||
Total Assets | |||||||||||
Current Liabilities | |||||||||||
Accounts Payable | |||||||||||
Deferred Revenues | |||||||||||
Debt, Current | |||||||||||
Accrued Liabilities | |||||||||||
Other Current Liabilities | |||||||||||
Total Current Liabilities | |||||||||||
Non-Current Liabilities | |||||||||||
Deferred Revenues | |||||||||||
Debt, Non-Current | |||||||||||
Other Non-Current Liabilities | |||||||||||
Total Non-Current Liabilities | |||||||||||
Total Liabilities | |||||||||||
Shareholders' Equity | |||||||||||
Common Stock | |||||||||||
Additional Paid-In Capital | |||||||||||
Retained Earnings | |||||||||||
Other Shareholders' Equity | |||||||||||
Total Shareholders' Equity | |||||||||||
Total Liabilities & Shareholders' Equity |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||
Net Income | |||||||||||
Depreciation & Amortization | |||||||||||
Deferred Income Taxes | |||||||||||
Stock Based Compensation | |||||||||||
Accounts Receivable | |||||||||||
Inventory | |||||||||||
Accounts Payable | |||||||||||
Deferred Revenue | |||||||||||
Other Non-Cash | |||||||||||
Operating Cash Flow | |||||||||||
Cash Flows from Investing Activities | |||||||||||
PPE Investments | |||||||||||
Net Acquisitions | |||||||||||
Purchase of Investments | |||||||||||
Sale of Investments | |||||||||||
Other Investing Activity | |||||||||||
Investing Cash Flow | |||||||||||
Cash Flows from Financing Activities | |||||||||||
Debt Issued | |||||||||||
Proceeds from Debt Repayment | |||||||||||
Debt Repayment | |||||||||||
Proceeds from Sale of Equity | |||||||||||
Equity Repurchased | |||||||||||
Dividend Paid | |||||||||||
Other Financing Activity | |||||||||||
Financing Cash Flow | |||||||||||
Cash Position | |||||||||||
Beginning Cash Position | |||||||||||
End Cash Position | |||||||||||
Change in Cash | |||||||||||
Free Cash Flow | |||||||||||
Operating Cash Flow | |||||||||||
Capital Expenditure | |||||||||||
Free Cash Flow |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||
Net Income | |||||||||||
Depreciation & Amortization | |||||||||||
Deferred Income Taxes | |||||||||||
Stock Based Compensation | |||||||||||
Accounts Receivable | |||||||||||
Inventory | |||||||||||
Accounts Payable | |||||||||||
Deferred Revenue | |||||||||||
Other Non-Cash | |||||||||||
Operating Cash Flow | |||||||||||
Cash Flows from Investing Activities | |||||||||||
PPE Investments | |||||||||||
Net Acquisitions | |||||||||||
Purchase of Investments | |||||||||||
Sale of Investments | |||||||||||
Other Investing Activity | |||||||||||
Investing Cash Flow | |||||||||||
Cash Flows from Financing Activities | |||||||||||
Debt Issued | |||||||||||
Proceeds from Debt Repayment | |||||||||||
Debt Repayment | |||||||||||
Proceeds from Sale of Equity | |||||||||||
Equity Repurchased | |||||||||||
Dividend Paid | |||||||||||
Other Financing Activity | |||||||||||
Financing Cash Flow | |||||||||||
Cash Position | |||||||||||
Beginning Cash Position | |||||||||||
End Cash Position | |||||||||||
Change in Cash | |||||||||||
Free Cash Flow | |||||||||||
Operating Cash Flow | |||||||||||
Capital Expenditure | |||||||||||
Free Cash Flow |